Reader response: Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

Genentech recognizes that high-quality and trustworthy guidelines, such as those published by the American Academy of Neurology, are important both for providers to optimize patient care and for payers to manage appropriate utilization of multiple sclerosis (MS) treatments.

Source link

Related posts

Tissue metabolite profiles for the characterisation of paediatric cerebellar tumours


10 Ideas for a Family Fresh Start: Reduce Screen Time


What Happens Later? The Lifelong Impact of Learning Disorders


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy